Cargando…
Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
MYC can be considered to be one of the most pressing and important targets for the development of novel anti-cancer therapies. This is due to its frequent dysregulation in tumors and due to the wide-ranging impact this dysregulation has on gene expression and cellular behavior. As a result, there ha...
Autores principales: | D’Avola, Annalisa, Kluckova, Katarina, Finch, Andrew J, Riches, John C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257908/ https://www.ncbi.nlm.nih.gov/pubmed/37309471 http://dx.doi.org/10.2147/OTT.S366627 |
Ejemplares similares
-
Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy
por: Kluckova, Katarina, et al.
Publicado: (2022) -
PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma
por: D’Avola, Annalisa, et al.
Publicado: (2022) -
B-cell Receptor Signaling Induced Metabolic Alterations in Chronic Lymphocytic Leukemia Can Be Partially Bypassed by TP53 Abnormalities
por: Kluckova, Katarina, et al.
Publicado: (2022) -
Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
por: Rebello, Richard J., et al.
Publicado: (2017) -
The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)